Latest Headlines

  1. Recipharm Invests In U.S. Fill-Finish Infrastructure To Accelerate Biologics Development 6/17/2026

    Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharmaceutical and biotechnology companies with advanced sterile fill and finish services for biologics and advanced therapies.

  2. Four Myths About Embedded CMOs, Busted 6/17/2026

    If you’re looking for a contract manufacturer to bring your therapy to market, you’re far from alone. Demand for manufacturing services is shaping the pharma Contract Manufacturing Industry, with analysts predicting a growth rate of nearly 7% per year until 2028.

  3. Avoiding Recalls: How To Ensure Sterility In Ophthalmic Products 6/17/2026

    In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract Manufacturing ensures product sterility and safety.

  4. Veranova Appoints Dr. Bob Huang Vice President And General Manager Of West Deptford Site 6/3/2026

    Veranova today announced the appointment of Dr. Bob Huang as Vice President and General Manager for its West Deptford, New Jersey facility. He will lead site operations, advance strategic growth initiatives, and strengthen manufacturing excellence and customer delivery.

  5. Leica Biosystems And CellCarta Expand Collaborative Companion Diagnostic Development Model To Accelerate Commercialization Globally 6/1/2026
  6. Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development 5/29/2026
  7. ILC Dover Expands Life Sciences Presence With Water For Injection (WFI) And Custom Chemical Solutions 5/26/2026
  8. Flexible Production: Körber Presents New Inspection And Packaging Innovations For The Global Market At Interpack 5/22/2026
  9. Green Star Organic Milling Strengthens Food Safety Program With METTLER TOLEDO Metal Detector 5/13/2026
  10. Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery 5/12/2026

    Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance‑enhancing company, today announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines.